Vincent Medical Holdings Limited

Vincent Medical Holdings Limited

HHKEX:1612
0.71
HKD
-0.03
(-4.08%)
547.01MMarket Cap
Mar 24Next Earn
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.68
0.81
1.1
0.84
0.7
0.77
0.79
1.8
1.19
0.96
1.11
1.25
1.45
- -
Basic EPS, GAAP
0.05
0.07
0.14
0.05
0.02
0.05
0.02
0.34
0.09
-0.03
0.09
0.11
0.16
- -
Free Cash Flow per Basic Share
0.07
0.04
0.11
0.02
-0.06
0.01
- -
0.22
0.14
0.09
0.09
-0.04
0.07
- -
Dividend per Share
0.03
0.04
0.05
0.03
0.02
0.02
0.02
0.01
0.13
0.05
0.01
0.03
0.04
- -
Book Value per Share
0.19
0.22
0.27
0.55
0.57
0.59
0.55
0.94
0.91
0.76
0.83
0.89
1.01
1.01
Tangible Book Value per Share
0.19
0.22
0.23
0.51
0.52
0.53
0.5
0.9
0.9
0.75
0.82
0.87
0.99
0.99
Basic Weighted Avg Shares
479
479
408
555
638
638
638
641
654
654
646
643
645
645
Sales/Revenue/Turnover
324
389
448
467
446
488
502
1,155
778
629
718
801
933
- -
Operating Margin (%)
10.87
13.74
15.19
9.03
9.55
8.73
6.17
26.74
12.62
-0.33
9.37
9.92
14.02
- -
Depreciation Expense
11
12
13
13
13
15
29
37
40
41
38
37
37
- -
Net Income, GAAP
23
36
58
29
13
31
12
217
61
-17
57
69
104
- -
Effective Tax Rate (%)
23.86
21.43
- -
22.25
41.61
10.3
29.72
12.9
9.23
- -
13.01
9.08
16.42
- -
Profit Margin (%)
7.22
9.19
12.98
6.26
2.95
6.34
2.29
18.77
7.8
-2.76
7.98
8.64
11.19
- -
Working Capital
107
105
142
325
263
253
243
367
408
333
336
316
342
342
LT Debt
- -
- -
4
1
- -
- -
12
1
5
5
2
60
138
138
Total Equity
147
169
217
401
415
434
414
605
600
499
543
583
673
673
Return on Invested Capital (%)
- -
20.66
- -
11.09
2.88
8.7
3.53
42.72
9.71
- -
9.65
11.11
13.78
- -
Return on Capital (%)
- -
18.34
- -
6.9
3.63
6.48
2.66
32.72
9.39
- -
10.15
10.87
13.19
- -
Return on Common Equity (%)
- -
27.63
37.78
11.24
3.67
8.37
3.17
44.99
10.03
-3.17
11.02
12.35
16.79
- -

Capital Structure

HKD

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
ST Debt
40
50
40
LT Borrowings
54
104
120
LT Finance Leases
6
9
18
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
653
653
659
Market Capitalization
261
320
547

Working Capital

HKD

•

in mil. unless spec.
Dec'24
Jun'25
Dec'25
Total Current Assets
588
696
699
Cash, Cash Equivalents & STI
173
204
251
Accounts Receivable, Net
169
231
195
Inventories
163
175
155
Total Current Liabilities
272
335
357
Payables & Accruals
- -
- -
- -
ST Debt
40
50
40
Deferred Revenue
- -
- -
- -

Growth Rates

HKD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
14.84%
2.8%
15.39%
Free Cash Flow
-669.98%
-97.5%
-278.5%
Net Income, GAAP
119.12%
-111.64%
50.91%
Sales/Revenue/Turnover
13.24%
-1.93%
16.46%
Total Cash Common Dividend
107.48%
231.79%
32.62%

Semi-annual Revenue

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
718
2024
- -
- -
801
2025
- -
- -
933

Semi-annual Earnings Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
0.09
2024
- -
- -
0.11
2025
- -
- -
0.16

Semi-annual Dividends Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
0.01
2024
- -
- -
0.03
2025
- -
- -
0.04

Company Description

CEO
Cheung Tai Choi
Full Time Employees
1,468
Sector
Health technology
Industry
Medical specialties
Address
Two Harbourfront Hong Kong Hong Kong
IPO Date
Jul 13, 2016
Business
Vincent Medical Holdings Limited, an investment holding company incorporated in the Cayman Islands in 1997 and headquartered at Units 1604-07A, 16th Floor, Two Harbourfront, 22 Tak Fung Street, Hung Hom, Kowloon, Hong Kong, researches, develops, manufactures, markets, trades in, and sells medical devices with production facilities in Dongguan, China, and R&D centers in Dongguan Songshan Lake Technology Industrial Park; the company operates through two segments, Original Equipment Manufacturing (OEM) and Original Brand Manufacturing (OBM), serving markets including the United States, Spain, Japan, the People's Republic of China, Costa Rica, the Netherlands, Australia, Germany, Sweden, Israel, and internationally. The company's core products encompass respiratory care devices such as high-flow oxygen therapy systems, respiratory humidification systems, nCPAP interface systems, respiratory care units, electronic air-oxygen blenders, anesthesia systems, and related disposables; imaging disposables including contrast media power injector syringes, tubing, and accessories; orthopedic and rehabilitation products comprising adjustable braces for skeletomuscular support and protection post-injury or surgery, rehab-robotics solutions, and robotic hand training devices under brands like Hand of Hope; as well as other healthcare and wellness products including surgical patient warming systems; products are marketed under Inspired Medical, inspired, and Hypnus brands. Vincent Medical Holdings Limited, a subsidiary of Vincent Raya International Limited, employs 1,328 staff and focuses on OEM partnerships with leading diagnostic imaging providers while expanding OBM offerings; in 2024, revenue grew 11.6% to HK$801.0 million, driven by a 37.7% surge in imaging disposables to HK$393.3 million, offsetting declines in respiratory (down 10.7% to HK$245.5 million) and orthopedic segments; the company achieved EU MDR certification for respiratory devices, passed FDA inspection with "No Action Indicated," launched an upgraded ERP system, entered a strategic smart manufacturing agreement with Siemens Digital Industries Software in April 2024, topped out Phase 1 of its new production facility in Kaiping City (trial operations by end-2025), and opened a Taobao store; for the six months ended June 30, 2025, revenue rose 18.1% to HK$449.4 million with profit up 55.1% to HK$51.6 million, declaring an interim dividend of HK2.4 cents per share.